Kodiak Sciences (KOD) Enterprise Value (2017 - 2026)
Kodiak Sciences (KOD) posted Enterprise Value of -$169.5 million for Q1 2026, up 19.22% on a QoQ basis from -$209.9 million in Q4 2025, and down 22.09% year-over-year from -$217.6 million in Q1 2025.
Kodiak Sciences (KOD) Enterprise Value (2017 - 2026) Analysis & Trends
Kodiak Sciences' Enterprise Value history runs 10 years deep, the most recent figure standing at -$169.5 million for Q1 2026.
- Quarterly Enterprise Value fell 22.09% year-over-year to -$169.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$169.5 million (down 22.09% YoY) and the FY2025 annual result came in at -$209.9 million, down 24.86% from the prior year.
- Enterprise Value was -$169.5 million for Q1 2026 at Kodiak Sciences, up from -$209.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$72.0 million in Q3 2025 and bottomed at -$671.7 million in Q1 2022.
- A 5-year average of -$308.8 million and a median of -$245.9 million in 2024 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 63.59% in 2025, while the deepest fall reached 24.86% in 2025.
- Kodiak Sciences' Enterprise Value stood at -$485.3 million in 2022, then jumped by 41.16% to -$285.5 million in 2023, then surged by 41.13% to -$168.1 million in 2024, then dropped by 24.86% to -$209.9 million in 2025, then grew by 19.22% to -$169.5 million in 2026.
- Business Quant data shows KOD's Enterprise Value at -$169.5 million in Q1 2026, -$209.9 million in Q4 2025, and -$72.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -169.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -169.53 Mn |
| Dec 31, 2025 | -209.86 Mn |
| Sep 30, 2025 | -72.04 Mn |
| Jun 30, 2025 | -104.17 Mn |
| Mar 31, 2025 | -138.85 Mn |
| Dec 31, 2024 | -168.07 Mn |
| Sep 30, 2024 | -197.86 Mn |
| Jun 30, 2024 | -219.23 Mn |
| Mar 31, 2024 | -245.92 Mn |
| Dec 31, 2023 | -285.51 Mn |
| Sep 30, 2023 | -345.67 Mn |
| Jun 30, 2023 | -378.67 Mn |
| Mar 31, 2023 | -421.19 Mn |
| Dec 31, 2022 | -485.26 Mn |
| Sep 30, 2022 | -537.40 Mn |
| Jun 30, 2022 | -597.88 Mn |
| Mar 31, 2022 | -671.73 Mn |
| Dec 31, 2021 | -731.51 Mn |
| Sep 30, 2021 | -799.25 Mn |
| Jun 30, 2021 | -880.87 Mn |